oxaliplatin, 130 mg / m2 IV D1

2 trials

Sponsors

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

Conditions

locally advanced gastric cancer/adenocarcinoma of the esophagogastric junction

Phase 2

Envolizumab combined with neoadjuvant chemotherapy in the treatment of locally advanced gastric cancer/adenocarcinoma of the esophagogastric junction: a prospective, one-arm, phase II clinical study

Active, not recruitingChiCTR2400087908

Peking Union Medical College Hospital, Chinese Academy of Medical Scienceslocally advanced gastric cancer/adenocarcinoma of the esophagogastric junction

Start: 2024-08-10Updated: 2024-08-12

A prospective randomized controlled clinical trail of Envorizumab combined with chemotherapy versus neoadjuvant chemotherapy alone in the treatment of locally advanced gastric cancer/adenocarcinoma of esophagogastric junction

Active, not recruitingChiCTR2400091812

Peking Union Medical College Hospital, Chinese Academy of Medical Scienceslocally advanced gastric cancer/adenocarcinoma of the esophagogastric junction

Start: 2024-11-04Updated: 2024-11-11